Gurugram, Haryana, India, January 2026 — Manish Lal Madan has been appointed as Chief Business Officer at Medsource Ozone Biomedicals Pvt. Ltd..
In his new role, Manish will be responsible for driving overall business strategy, strengthening commercial operations, expanding market presence, and accelerating growth across Medsource Ozone Biomedicals’ diagnostics portfolio, with a particular focus on emerging markets in Asia, Africa, and South America.
Prior to joining Medsource Ozone Biomedicals, Manish served as General Manager – Transfusion and Transplant at Werfen India, where he led business operations across specialised transfusion and transplant diagnostics, overseeing sales strategy, market expansion, and customer engagement initiatives.
Before Werfen India, he held the role of General Manager – India at Immucor India Private Ltd, following a long tenure at Immucor Inc. as Director – Sales and Business Development. Across these roles, he played a key part in scaling India operations, strengthening distributor networks, and driving sustained revenue growth in transfusion diagnostics.
Earlier in his career, Manish worked with Fresenius Kabi India Pvt Ltd as Business Manager – TT India, and with Fenwal India Pvt Ltd as Business Manager – India, where he was responsible for national revenue, sales strategy, distributor management, and execution of commercial plans aligned with Asia-Pacific and global strategies.
He began his professional journey at Baxter Healthcare, holding leadership roles in transfusion therapies, before spending nearly eight years at Pfizer as Senior Institutional District Manager, building a strong foundation in institutional sales and healthcare market development.
About Medsource Ozone Biomedicals Pvt. Ltd.
Medsource Ozone Biomedicals Pvt. Ltd. is a fast-growing, professionally managed organisation focused on the development, manufacturing, and marketing of clinical diagnostic products. Headquartered in New Delhi, India, the company offers a broad portfolio of IVD solutions across clinical chemistry, molecular diagnostics, serology, immunochromatographic, and immunofluorescence platforms, serving emerging markets across Asia, Africa, and South America.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
